world
기타 성향
Everest Medicines Enters into Exclusive Licensing Agreement with Travere Therapeutics for Civorebrutinib a Potential Best-in-Class BTK Inhibitor for Rare Kidney Diseases, Driving Value Conversion
Antara News (Indonesia)
조회 0
Everest Medicines (HKEX 1952.HK) announced that it has entered into an exclusive licensing and collaboration ...
관련 뉴스
관련 뉴스 제보는 로그인 후 가능합니다.